No two cancers are the same. Let's treat it that way.
Eigen Therapeutics is a biotechnology company developing co-therapies that improve the efficacy of targeted cancer treatments by modulating tumor cell-surface targets. Its AI-driven discovery platform combines high-throughput biology, laboratory robotics, and machine learning to identify combination therapies for cancers with heterogeneous target expression. The approach expands patient eligibility for existing targeted therapies while reducing side effects.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account